Long Covid voices 'excluded' from inquiry hearings
befunky.com
People with Long Covid are disappointed their voices will not be prioritised as part of public hearings about the government's pandemic response.
Phase two of the Royal Commission of Inquiry into the official response to Covid-19 gets underway in Auckland today, and will run until Thursday.
It will hear from everyday people and their experiences of the government's decisions over vaccine use and lockdowns, including the extended lockdowns in Auckland and Northland. It will also hear from businesses and organisations affected.
Long Covid Support Aotearoa spokesperson Catherine Appleby said she felt in choosing its focus, the inuiry had missed an opportunity to include the perspectives of people with post-Covid conditions.
"A massive mistake really, to do that, because we were directly affected and our lives are still particularly affected as well."
Appleby worked as a nurse at an urgent care centre when Covid-19 hit in 2020.
Each day, after her shift, she would have to strip down her clothes on her doorstep, in the hope she wouldn't transmit Covid to her whānau. It's something many other healthcare practitioners did.
In 2022, she caught Covid-19 herself. She returned to work thinking she was recovered, but the symptoms didn't go away.
She reduced her hours of work in the hope it would improve things, but it didn't.
"Finally, I just had to decide, and at that stage, I was over two and a half years into Long Covid, and I thought, "I'm looking down the barrel of non-recovery. If I want to have any chance of recovery, I just have to stop working completely."
Auckland spent more than 100 days in lockdown starting in August 2021.
Photo:
123RF
Appleby explained that there are significant impacts on people with Long Covid.
It often affects their ability to work, leading to loss of income, lack of financial and health system support, and impacts on social and family life, she said.
She said thousands of people experience Long Covid across Aotearoa, all the more reason to include their voices in the hearings this week.
"Covid is still around, and the Long Covid numbers are likely to increase. Even if you are immunized, the estimate is up to 10% of people who catch the infection will get Long Covid."
Long Covid Support Aotearoa has called for an inquiry into the condition, much like the one held across the ditch in Australia between 2022 and 2023.
A new Otago-led study, published in the International Journal of Paediatrics and Child Health, found that more than 20 per cent of children and young people in Aotearoa are experiencing significant, persistent health symptoms following Covid-19.
Lead Author and Associate Professor from the University of Otago's Department of Public Health, Julie Bennett, said her team conducted interviews with nearly 4300 children (or their parents for those under 16) to understand their experiences and symptoms after Covid-19 infection.
The symptoms included things like headaches, fatigue, coughs, and anxiety, which they didn't have before having Covid, she said.
"They were also reporting that they were unable to attend school because of having these symptoms, or they were unable to attend things like going to sporting events or activities that they normally would be able to do. These symptoms weren't just happening; they were actually limiting their ability to be able to participate in life."
Regarding New Zealand's response, Professor Bennett said having a proper pandemic plan in place is key.
"We did manage to get together really quickly, a good group of people to be able to make decisions, and making really hard decisions, on the spur of the moment, often with little information, but trying to do it as evidence-based as they could."
Instead of focusing on Long Covid, the hearings this week will cover Government decisions relating to lockdowns, vaccine mandates, and vaccine safety, and how these key decisions affected things like social division and isolation, health and education, and business activity.
Hearings this week are part of phase two of the Royal Commission's Inquiry.
Photo:
www.covid19lessons.royalcommission.nz
Restaurant Association chief executive Marisa Bidois has been an outspoken voice on the economic toll that successive lockdowns have had on the hospitality industry, especially in Auckland.
She said the restrictions saw multiple businesses close as a result, a hard hit on her industry.
"If there were some different decisions made around the lockdowns, the restrictions in trading, we would still see some of those businesses operating today, no doubt."
At the time, she was an outspoken voice, consistently advocating for change and raising suggestions on how businesses could survive while also balancing public health goals.
She said that while the government's intention might have been to protect public health, the reality felt like a one-size-fits-all approach.
"We did a significant amount of work around the ways to make, like contactless deliveries available at, say, alert level three. Feedback like this, at the time, was ignored, whereas if that would have been taken on board, businesses could have been operating sooner."
Marisa Bidois said the last couple of years have been particularly tough on the hospotality industry.
Photo:
Supplied
The Restaurant Association submitted its feedback in writing and is not currently scheduled to appear at the hearings.
Still, Bidois is welcoming the chance for reflection.
"It's such a critical opportunity to ensure that we learn lessons from that pandemic response so that we can be better prepared, better informed for anything that may come about in the future," she said.
Phase one was originally announced in 2022 by then-Prime Minister Jacinda Ardern; it aimed to examine the lessons learned and help the country better prepare for future pandemics.
The second phase was borne from National's coalition agreements with both ACT and NZ First.
It will cover vaccine approval, safety, monitoring, and mandates; the imposition and maintenance of national and regional lockdowns; The procurement, development, and distribution of testing and tracing technologies and non-pharmaceutical public health material.
Inquiry chair Grant Illingworth said this process was not about placing blame, but instead about learning.
"We are instructed in our terms of reference to avoid legalistic and adversarial processes. We are instructed to try to achieve the purpose of the inquiry, which is not to judge people or to hold them up to public scorn."
In 2022 hundreds of cars and a few thousand people descended on central Wellington and Parliament to protest against the Government's Covid-19 vaccine mandates.
Photo:
VNP / Phil Smith
Covid-19 lockdowns and vaccines have been the subject of misinformation and controversy in the last few years.
Illingworth explained that the hearings will be live-streamed on the Royal Commission's website, improving accessibility and transparency.
"Obviously we are not in a position to wave a magic wand and ensure that New Zealand is united over this whole issue. But it is, of course, important for us to try to help New Zealand to come together so that we do have an united ability to stand up to any crises in the future."
Part two of the public hearings will take place at the end of August in Wellington and will hear from those who were key decision makers during the pandemic.
Sign up for Ngā Pitopito Kōrero
,
a daily newsletter curated by our editors and delivered straight to your inbox every weekday.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
RNZ News
an hour ago
- RNZ News
Weight loss drug Wegovy: The pros and cons, explained
This story has been corrected as an earlier version said Wegovy AND Ozempic had been made available on prescription for weight loss in New Zealand but it is only Wegovy. Wegovy is injected daily and promotes a feeling of fullness while silencing "food noise." Photo: LISE ASERUD Earlier this week semaglutide drug Wegovy was made available for prescription in New Zealand . Semaglutide originally arrived on the market in the US in 2017 as a diabetes medication, but has quickly been tied to extreme weight loss . Wegovy can be prescribed to people over the age of 12, but many of the 65 percent of New Zealanders who are overweight or obese will have trouble affording it, with an estimated price of $500 a month. The drug has transformed our ability to manage obesity and type 2 diabetes, and has shown potential for a wide range of conditions such as Alzheimer's, addiction and depression. But there are clouds to go along with the silver linings - such as potential vision loss. "This condition, it occurs when there's insufficient blood flow to the nerves connecting the eye to the brain, and this leads to damage," US-based health reporter for New Scientist , Grace Wade, told RNZ's Sunday Morning . The specific condition was non-arteritic anterior ischemic optic neuropathy. "That can cause this sudden and permanent vision loss, usually in just one eye. Now, I should be clear this isn't total vision loss, at least usually - it's more like cloudiness, stuff like that." People using semaglutides to treat diabetes were 4.3 times more likely to develop this condition, and those using it for weight loss 7.6 times, as people using other types of diabetes medications, a 2024 study found (Wade wrote about it in New Scientist here ). Novo Nordisk, the maker of Wegovy, said in a statement, patient safety was the top priority and all reports of adverse events were taken seriously. "Semaglutide has been studied in robust clinical development programs with more than 52,000 semaglutide exposed patients and exposure from post-marketing use of over 33 million patient years." It said it was recommended to update patient leaflets for Wegovy and Ozempic on June 6 to include the condition under its special warnings and precautions for use and as an adverse drug reaction with a frequency of "very rare, meaning it may effect up to 1 in 10,000 people taking semaglutide". It said based on the totality of evidence it concluded the data did not suggest a reasonable possibility of a casual relationship between the condition and semaglutide and "the benefit-risk profile of semaglutide remains favourable". "We work closely with authorities and regulatory bodies worldwide to continuously monitor the safety profile of our products." The drug worked by suppressing appetite, which typically leads to weight loss as people consume fewer calories. But the weight lost was not always beneficial, Wade said. "It leads the body to break down fat, muscle and actually even bone for nutrients, and that's why… some research has found that upwards of 40 percent of the weight loss seen with these medications is due to loss of muscle mass… that makes it really important that people prioritise exercise when taking these drugs because if you don't use your muscle, you're more likely to lose it." Getting into the exercise habit was also important since one day, most people on Wegovy will stop taking it - putting themselves at risk of putting the weight back on if they were not regularly moving. Then there is 'Ozempic face'. "I don't think this is a clinical term yet, but it's something that's popped up a lot in social media," Wade said. "People who are taking these medications start developing... a sunken or hollowed out appearance, which can exacerbate fine lines and wrinkles, make their skin look a little more saggy. "It isn't clear exactly how common this is… but it probably has to do with just weight loss, right? If you're losing weight, as much as some people would want to target their weight loss to certain areas of their body, we can't really do that. So, you know, any sort of overall weight loss is also gonna cause a loss of fat in your face." There were also side effects for some, including constantly needing to go to the toilet, feeling bloated, belching, constipation, heartburn, fever, upset stomach - the list, collected here by the Mayo Clinic, goes on . And nearly half of people who try it make it through a three-month course, one study found. Wade also mentioned a lot of people taking semaglutide for diabetes or Alzheimer's prevention might be older and "frail", so not able to lose weight. "Drug developers are actually working to develop new drugs that have similar effects as these weight loss medications, but without the weight loss." One unexpected benefit of semaglutide was its apparent effect on not just calorie consumption, but use of addictive substances, such as alcohol and nicotine. "We aren't exactly sure why that is, but it appears to be with how these medications affect brain activity. "So these drugs curb cravings for alcohol similar to how they curb cravings for food, right? And that probably has to do with their impact on brain regions involved in reward processing and craving… "A study of more than half-a-million people with a history of opioid use disorders showed that those who took Ozempic or similar [medications] had significantly lower rates of opioid overdose than those who didn't. Grace Wade. Photo: New Scientist "Other studies have shown similar effects in people with cannabis use disorder, cigarette smokers and alcoholism." Scientists did not expect this effect, calling it an "unintended consequence". The drugs have also shown promise in reducing heart attacks and strokes, improving fertility, treating pain, improving mental health, lower the risk of kidney failure and slowing cognitive decline. "I've never encountered a group of drugs like this," Wade said. "That's what makes these drugs so remarkable, because most medications can only treat one or two conditions, right?" She said it was likely that weight loss was playing a role - as it frequently does in health - but "it doesn't seem to be the only [reason]". But there is still a lot of research to be done, she said, before we all start taking it. "Let's unravel how they can treat all of these conditions before we jump the gun and start suggesting we, you know, maybe put it in everyone's water or something." Sign up for Ngā Pitopito Kōrero, a daily newsletter curated by our editors and delivered straight to your inbox every weekday.
Scoop
2 hours ago
- Scoop
Covid-19 Inquiry: Who Is Being 'Excluded' From Inquiry Hearings
, (Ngāpuhi, Te Māhurehure, Ngāti Manu) Longform Journalist, Te Ao Māori People with Long Covid are disappointed they will not be prioritised as part of public hearings about the government's pandemic response. Phase two of the Royal Commission of Inquiry into the official response to Covid-19 gets underway in Auckland on Monday, and will run until Thursday. It will hear from everyday people and their experiences of the government's decisions over vaccine use and lockdowns, including the extended lockdowns in Auckland and Northland. It will also hear from businesses and organisations affected. Long Covid Support Aotearoa spokesperson Catherine Appleby said she felt in choosing its focus, the inuiry had missed an opportunity to include the perspectives of people with post-Covid conditions. "A massive mistake really, to do that, because we were directly affected and our lives are still particularly affected as well." Appleby worked as a nurse at an urgent care centre when Covid-19 hit in 2020. Each day, after her shift, she would have to strip down her clothes on her doorstep, in the hope she wouldn't transmit Covid to her whānau. It's something many other healthcare practitioners did. In 2022, she caught Covid-19 herself. She returned to work thinking she was recovered, but the symptoms didn't go away. She reduced her hours of work in the hope it would improve things, but it didn't. "Finally, I just had to decide, and at that stage, I was over two and a half years into Long Covid, and I thought, "I'm looking down the barrel of non-recovery. If I want to have any chance of recovery, I just have to stop working completely." Appleby explained there were significant effects on people with Long Covid. It often affects their ability to work, leading to loss of income, lack of financial and health system support, and impacts on social and family life, she said. She said thousands of people experience Long Covid across Aotearoa, all the more reason to include their voices in the hearings this week. "Covid is still around, and the Long Covid numbers are likely to increase. Even if you are immunized, the estimate is up to 10% of people who catch the infection will get Long Covid." Long Covid Support Aotearoa has called for an inquiry into the condition, much like the one held across the ditch in Australia between 2022 and 2023. A new Otago-led study, published in the International Journal of Paediatrics and Child Health, found that more than 20 per cent of children and young people in Aotearoa are experiencing significant, persistent health symptoms following Covid-19. Lead Author and Associate Professor from the University of Otago's Department of Public Health, Julie Bennett, said her team conducted interviews with nearly 4300 children (or their parents for those under 16) to understand their experiences and symptoms after Covid-19 infection. The symptoms included things like headaches, fatigue, coughs, and anxiety, which they didn't have before having Covid, she said. "They were also reporting that they were unable to attend school because of having these symptoms, or they were unable to attend things like going to sporting events or activities that they normally would be able to do. These symptoms weren't just happening; they were actually limiting their ability to be able to participate in life." Regarding New Zealand's response, Professor Bennett said having a proper pandemic plan in place is key. "We did manage to get together really quickly, a good group of people to be able to make decisions, and making really hard decisions, on the spur of the moment, often with little information, but trying to do it as evidence-based as they could." Instead of focusing on Long Covid, the hearings this week will cover Government decisions relating to lockdowns, vaccine mandates, and vaccine safety, and how these key decisions affected things like social division and isolation, health and education, and business activity. Restaurant Association chief executive Marisa Bidois has been an outspoken voice on the economic toll that successive lockdowns have had on the hospitality industry, especially in Auckland. She said the restrictions saw multiple businesses close as a result, a hard hit on her industry. "If there were some different decisions made around the lockdowns, the restrictions in trading, we would still see some of those businesses operating today, no doubt." At the time, she was an outspoken voice, consistently advocating for change and raising suggestions on how businesses could survive while also balancing public health goals. She said that while the government's intention might have been to protect public health, the reality felt like a one-size-fits-all approach. "We did a significant amount of work around the ways to make, like contactless deliveries available at, say, alert level three. Feedback like this, at the time, was ignored, whereas if that would have been taken on board, businesses could have been operating sooner." The Restaurant Association submitted its feedback in writing and is not currently scheduled to appear at the hearings. Still, Bidois is welcoming the chance for reflection. "It's such a critical opportunity to ensure that we learn lessons from that pandemic response so that we can be better prepared, better informed for anything that may come about in the future," she said. Phase one was originally announced in 2022 by then-Prime Minister Jacinda Ardern; it aimed to examine the lessons learned and help the country better prepare for future pandemics. The second phase was borne from National's coalition agreements with both ACT and NZ First. It will cover vaccine approval, safety, monitoring, and mandates; the imposition and maintenance of national and regional lockdowns; The procurement, development, and distribution of testing and tracing technologies and non-pharmaceutical public health material. Inquiry chair Grant Illingworth said this process was not about placing blame, but instead about learning. "We are instructed in our terms of reference to avoid legalistic and adversarial processes. We are instructed to try to achieve the purpose of the inquiry, which is not to judge people or to hold them up to public scorn." Covid-19 lockdowns and vaccines have been the subject of misinformation and controversy in the last few years. Illingworth explained that the hearings will be live-streamed on the Royal Commission's website, improving accessibility and transparency. "Obviously we are not in a position to wave a magic wand and ensure that New Zealand is united over this whole issue. But it is, of course, important for us to try to help New Zealand to come together so that we do have an united ability to stand up to any crises in the future." Part two of the public hearings will take place at the end of August in Wellington and will hear from those who were key decision makers during the pandemic.
RNZ News
2 hours ago
- RNZ News
As it happened: First public hearings into New Zealand's Covid-19 response begin
Heart of the City chief executive Viv Beck, right, and employment relations and safety manager Paul Jarvie. Photo: The first public hearings into New Zealand's Covid response get under way on Monday - with a focus on lockdowns and vaccines. The Royal Commission of Inquiry into Covid-19 is looking into the government's response to the pandemic and its effects. It is the first time submissions will be heard publicly, with the sessions livestreamed. You can follow updates from today in our live blog above. This week's hearings particularly concentrate on the impact of the extended lockdown in Auckland and Northland in 2021 and on vaccine mandates and safety. In a minute issued on the Inquiry's website chair Grant Illingworth KC said that would include the effect on "social division and isolation, health and education, and business activity. Covid 19 response Inquiry chair Grant Illingworth KC. Photo: Screengrab / Covid 19 Inquiry "We will also hear from experts about the key decisions and their consequences, and lessons to be learned from what happened." The hearings would be in secure hearing rooms, with commissioners, witnesses, lawyers and media present. There was no provision for public attendance beyond those submitting but the live streams would run and be available as recordings as well, the minute said. Witnesses would be questioned by lawyers helping the inquiry, and commissioners could ask questions. A second public hearing was due next month in Wellington. That was to hear from key decisions makers who "led and informed" the government's response to the pandemic. This Royal Commission was set up under the previous Labour government, but its brief was expanded under the current government, with Illingworth taking the chairing role. A report from the first phase was delivered last year. Sign up for Ngā Pitopito Kōrero , a daily newsletter curated by our editors and delivered straight to your inbox every weekday.
